T1	Participants 297 410	Sixty-two patients (19 men and 43 women; mean age, 54 years; range, 32-77 years) with heartburn and regurgitation
T2	Participants 808 836	the group given lansoprazole
T3	Participants 851 874	the group given placebo
T4	Participants 988 1016	he groups given lansoprazole
T5	Participants 1391 1419	patients with reflux symptom
